GNS Healthcare Uncovers Novel Targets for Triple-Negative Breast Cancer Using Causal Machine Learning and Simulation Platform REFS™

New Gene Discoveries Published by the American Association for Cancer Research CAMBRIDGE, Mass. – May 31, 2017– Leading precision medicine company GNS Healthcare (GNS), today announced the discovery of novel targets, including TRIB1, which correlates with survival, progression, and metastasis in resistant breast cancer. The study, which was conducted at University of California, San Francisco, […]

Big Data Analytics Research Projects Target Cancer, Genomics

Several recently announced collaborations between academic research institutions and big data analytics vendors powering advanced discovery technologies will bring the power of big data to new studies that may have significant impacts on future therapies and treatments.  With oncology and genomics in the spotlight, personalized medicine is poised to take a leap forward as researchers […]

Alliance for Clinical Trials in Oncology and GNS Healthcare Launch Big Data Initiative to Transform Metastatic Colorectal Cancer Treatment

Partners to Apply Causal Machine Learning and Simulation to Combination Treatment Regimens to Discover Biomarkers of Clinical Response to Treatment CHICAGO, Ill. and CAMBRIDGE, Mass. – Dec. 15, 2015 – The Alliance for Clinical Trials in Oncology (the Alliance), one of the five cooperative research groups in the United States sponsored by the National Cancer […]

Hartford Courant: Aetna Study Uses Data To Predict Risk Of Metabolic Syndrome

Aetna and a data analytics firm looked at medical claims of 37,000 policyholders to find the likelihood that those patients are at a risk of metabolic syndrome, according to research published last week in the American Journal of Managed Care. Metabolic syndrome is characterized by five factors: a large waist size, high blood pressure, high […]